CPH2 eyes commercialisation in 2022 year-end report

UK-based CPH2 has today (April 20) announced its inaugural financial results and report for 2022, with eyes on commercialisation.

The company, which developed its Membrane-Free Electrolyser (MFE) technology, revealed after admission to the London Stock Exchange-operated AIM market in February last year (2022), it raised gross proceeds of £30.5m ($37.9m).

With a year-end net asset position of £25.3m, the company said £15.3m ($19.04m) was in cash or current assets investments (bank deposits).

... to continue reading you must be subscribed

Subscribe Today

Paywall Asset Header Graphic

To gain access to this article and all our other content, you will need to subscribe to H2 View.

From the latest print editions, to 24/7 online access to exclusive interviews, authoritative columnists and the H2 View news archive, a subscription is the best way for you to stay up to date with developments in the hydrogen community.

Please wait...